Lenart-Lipińska M et al. showed that serum FGF21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at 24 months follow-up [40]. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.